153 related articles for article (PubMed ID: 37533109)
1. PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer.
Li X; Liu H; Zhou X; Zhou Y; Zhang Y; Liou YL; Zeng M; Zhu H
Clin Epigenetics; 2023 Aug; 15(1):123. PubMed ID: 37533109
[TBL] [Abstract][Full Text] [Related]
2. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
3. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
4. Methylation of
Li X; Zhou X; Zeng M; Zhou Y; Zhang Y; Liou YL; Zhu H
J Cancer; 2021; 12(17):5136-5143. PubMed ID: 34335930
[No Abstract] [Full Text] [Related]
5. PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women.
He L; Luo X; Bu Q; Jin J; Zhou S; He S; Zhang L; Lin Y; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2179916. PubMed ID: 36799003
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
7. Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Zhang L; Hu D; Wang S; Zhang Y; Pang L; Tao L; Jia W
Gene; 2020 Jan; 723():144142. PubMed ID: 31589957
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
9. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
10. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.
Liu H; Meng X; Wang J
Int J Gynecol Cancer; 2020 Oct; 30(10):1488-1492. PubMed ID: 32616628
[TBL] [Abstract][Full Text] [Related]
11. High
Li X; He S; Zhao X; Sun D; Wu S; Xu D; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1820-1829. PubMed ID: 38448375
[TBL] [Abstract][Full Text] [Related]
12. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
13. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
14. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
[TBL] [Abstract][Full Text] [Related]
15.
Zhao Z; Zhang X; Zhao X; Cai J; Wu NY; Wang J
Biomed Res Int; 2020; 2020():3981529. PubMed ID: 33376722
[TBL] [Abstract][Full Text] [Related]
16. Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
Liou YL; Zhang TL; Yan T; Yeh CT; Kang YN; Cao L; Wu N; Chang CF; Wang HJ; Yen C; Chu TY; Zhang Y; Zhang Y; Zhou H
Clin Epigenetics; 2016; 8():66. PubMed ID: 27293491
[TBL] [Abstract][Full Text] [Related]
17. PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
Luan T; Hua Q; Liu X; Xu P; Gu Y; Qian H; Yan L; Xu X; Geng R; Zeng X; Li P
Int J Gynecol Cancer; 2017 Sep; 27(7):1480-1488. PubMed ID: 28472814
[TBL] [Abstract][Full Text] [Related]
18. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
[TBL] [Abstract][Full Text] [Related]
19. PAX1 Methylation Hallmarks Promising Accuracy for Cervical Cancer Screening in Asians: Results from a Meta-Analysis.
Kong LY; Du W; Wang L; Yang Z; Zhang HS
Clin Lab; 2015; 61(10):1471-9. PubMed ID: 26642709
[TBL] [Abstract][Full Text] [Related]
20. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
